Background-This study tested the hypothesis that moderate alcohol intake exerts its cardioprotective effect mainly through an increase in the serum level of high-density lipoprotein cholesterol. Methods and Results-In the Cohort of Norway (CONOR) study, 149 729 adult participants, recruited from 1994 to 2003, were followed by linkage to the Cause of Death Registry until 2006. At recruitment, questionnaire data on alcohol intake were collected, and the concentration of high-density lipoprotein cholesterol in serum was measured. Using Cox regression, we found that the adjusted hazard ratio for men for dying from coronary heart disease was 0.52 (95% confidence interval, 0.39 -0.69) when consuming alcohol more than once a week compared with never or rarely. The ratio changed only slightly, to 0.55 (0.41-0.73), after the regression model included the serum level of high-density cholesterol. For women, the corresponding hazard ratios were 0.62 (0.32-1.23) and 0.68 (0.34 -1.34), respectively. Conclusions-Alcohol intake is related to a reduced risk of death from coronary heart disease in the follow-up of a large, population-based Norwegian cohort study with extensive control for confounding factors. Our findings suggest that the serum level of high-density cholesterol is not an important intermediate variable in the possible causal pathway between moderate alcohol intake and coronary heart disease. (Circulation. 2011;124:00-00.)
A decreased risk of coronary heart disease (CHD) after consumption of moderate amounts of alcohol has been found in many cohort studies. In a recent meta-analysis, the mean relative risk for both fatal and nonfatal coronary heart disease was 0.75 when drinkers were compared with nondrinkers. 1 Several reasons have been presented in order to explain why the association is noncausal, and one of these is that nondrinkers are a mix of lifelong abstainers and former drinkers. 2, 3 The latter group may include subjects who have stopped drinking due to health problems (sick quitters). However, several prospective studies have been able to differentiate between never-drinkers and former drinkers, and have not found that the sick quitter hypothesis can fully explain the observation of a beneficial effect of moderate alcohol intake. 4 -6 
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Based on effects of alcohol consumption in interventional studies, changes in high-density lipoprotein cholesterol (HDL-C), apolipoprotein A, fibrinogen, and adiponectin have been put forward as possible mechanisms for the reduced risk of CHD. 7 Such short-term interventions can only be suggestive, because no cardiovascular end point is measured. Recently, Rimm and Moats calculated that HDL-C is the most important of the investigated biomarkers explaining the benefit of alcohol in both men and women. 8 HDL-C is of particular interest, because controlled experimental repeated intake of alcohol is known to increase the serum concentration of this lipoprotein. 9 Some studies have suggested that up to 50% of the cardioprotective effect of alcohol consumption can be explained by changes in the serum level of HDL-C. 10 -12 However, in the Helsinki Heart Study, HDL-C only explained 16% of the effect. 13 Although European countries are becoming more similar in drinking patterns, Norway is still a country with a relatively low total consumption of alcohol per capita. 14 The per capita consumption in countries like Denmark, United Kingdom, Spain, and France is about twice as high as that in Norway. 14 In Norway, alcohol is usually not included as part of everyday meals, which suggests that relatively few people will consume alcohol more than once or twice a week. Against this low-consumption background and the unresolved mechanism of cardioprotection, we aimed to estimate the association between moderate alcohol intake and death from CHD in the general Norwegian population and to test the hypothesis that HDL-C is a main intermediate variable using a large cohort study with lipid measures at baseline.
Methods

Study Population
The source population is the Cohort of Norway (CONOR) study, which includes 173 243 subjects who have participated in 1 of 10 regional, population-based health surveys in the period of 1994 -2003. 15 Subjects were invited to participate in a health examination that included anthropometrical measures, blood sampling, and questionnaires. The overall response rate was 58.3%. The data set was linked to the Norwegian Cause of Death Registry for the period of 1994 to 2006. For our purpose, we only included subjects who reported at the time of the recruitment that they did not have a history of heart disease (heart infarction or angina pectoris), cerebrovascular disease (stroke), or diabetes mellitus, which left 154 222 subjects. Among these subjects, we excluded those who had not responded to any question regarding alcohol consumption, which resulted in a study population of 149 729 subjects.
Measurements
CONOR includes certain core questions and measures (see www.fhi.no). The main exposure variable is a frequency measure of alcohol intake that was constructed from 3 questions: "How many times have you consumed alcohol during the past month?" (available in 3 surveys), where a number is asked for, and "How often have you consumed alcohol during the past year?" (available in all 10 surveys), with several categorical response categories, combined with the item: "Are you a total abstainer?" (available in 3 surveys). The response categories based on these variables for alcohol intake in the present study are shown in Tables 1 and 2 . The variable introduced as a possible mediating factor for the effect of alcohol on CHD is serum HDL-C (mmol/L). Based on their status as risk factors for CHD, we chose to include the following variables as potential confounders, all of which were measured at the time of recruitment: body mass index (kg/m 2 ), serum total cholesterol (mmol/L), serum triglycerides (mmol/L), systolic and diastolic blood pressure (mm Hg: mean of 2 measurements), educational attainment (years), hard physical activity in leisure time during past year (hours per week), smoking (yes/no), age at examination (years), and whether the subject was living with a spouse or cohabitant (yes/no). The mean values and frequency distributions of these variables for men and women are shown in Tables 1 and 2 
Statistical Analysis
For descriptive analyses, means with standard errors are given for continuous variables, and frequency distributions are used for categorical variables. We used multivariable Cox regression to estimate crude and adjusted hazard ratios for death from CHD according to category of alcohol intake, using SPSS, version 17. Life years of observation were calculated from the year of examination until the year of emigration or death, or until December 31, 2006. The analytic strategy was to examine the effect of alcohol intake on CHD mortality by adjusting first for the effect of age; secondly for the other potential confounders mentioned above to estimate as much of the direct effect of alcohol intake as possible; and lastly to introduce HDL-C to see if the hazard ratios changed. Years of education and physical activity during leisure time were used as categorical variables and included missing categories. Systolic and diastolic blood pressures were highly correlated (Pearson correlation coefficient 0.75), and only the diastolic pressure was used in the regression. Tables 1 and 2 show the distributions of covariates according to self-reported alcohol intake. There was an increase in mean serum HDL-C levels as reported alcohol intake increased. In contrast, there was a decrease in mean levels of triglycerides, total cholesterol, and blood pressure with increasing alcohol consumption. Subjects who rarely or never drank alcohol were older and more often nonsmokers. Subjects with the highest alcohol intake had the highest educational level.
Results
The age-adjusted hazard ratio for CHD steadily declined as alcohol intake at recruitment to the study increased (Table 3) . For both men and women, little change was seen in the effect of alcohol intake after inclusion of potential confounders in the regression model (Table 4 , models 1 and 2). When HDL-C was added (Table 4 , model 3), only small increases in the hazard ratios were found.
Discussion
Our main finding is that the association between alcohol intake and death from CHD did not change substantially when taking the serum level of HDL-C into account. A possible interpretation is that HDL-C is not a major mechanism for the protective effect of alcohol on coronary heart disease. As suggested by the multivariate analyses, HDL-C and alcohol intake have mainly independent effects on the risk of dying from heart disease. We also found that other risk factors for heart disease, such as smoking, blood pressure, serum total cholesterol, and triglycerides, as well as physical activity, educational level, or body mass index, did not confound the association between alcohol and coronary heart disease.
The strength of the study is the large sample size compared with previous studies, 10 -13 as well as the standardized physical examination with analyses of blood samples using reliable methods 16 in a prospective setting. It is a weakness that the exposure was only assessed at one point in time and that neither the alcohol information nor the CHD end points in the Cause of Death Registry have been strictly validated. However, if these independently measured variables were invalid or unreliable, one would hardly find such a clear association. A strong effect of selection bias is also hard to imagine, because that would suggest that the association was the opposite among nonparticipants. An attrition study of 1 of the CONOR subsamples, HUNT, indicated only a small selection bias as concerns drinking behavior. Nonsignificant odds ratios for nonparticipation ranged from 0.96 to 1.13 for various levels of drinking compared with rarely drinking nonabstainers, whereas the odds ratio for nonresponse among abstainers was 1.41 (PϽ0.001). 17 There is reason to believe that actual alcohol intake is underreported. Statistics Norway has estimated the yearly average alcohol consumption for people 15 years of age during the study period to be between 4.7 and 6.5 L of pure alcohol. 18 This would correspond to Ϸ1 unit per day if everybody had the same intake. One study has shown that 90% of all alcohol consumed in the United States was drunk by the upper 20% of consumers. 19 Assuming the same pattern in Norway, 20% of the Norwegian population should be expected to drink on average 4.5 units per day. In our study, even among men, only 16% reported drinking more regularly than once a week, which may reflect somewhat lower participation by heavy drinkers, but which probably mainly reflects underreporting.
We found that HDL-C levels increase with increasing intake of alcohol for both sexes (Tables 1 and 2 ), in agreement with the established role of HDL-C as a biomarker of alcohol intake. According to Rimm et al, 9 HDL-C concentrations will increase by 0.133 mg/dL, ie, 0.0035 mmol/L per gram of alcohol consumed a day. For men in our study (Table   1 ) who reported drinking 1-3 times per month and who had a mean HDL-C level of 1.237 mmol/L, this would suggest that they on average consumed 9 g of alcohol per day more than those who reported that they never or rarely consumed alcohol, and who had a mean level of 1.204 mmol/L. For the group reporting alcohol intake once a week and those consuming more than once a week, such calculations, based on mean HDL-C levels, suggest average daily consumption levels of 27 and 57 g, respectively, compared with the never/rarely group. Similar calculations for women (Table 2) suggest average daily alcohol intakes of 16, 37, and 69 g more than the never/rarely group for the 1 to 3 times per month, 1 time per week, and more than once a week, respectively. These calculations based on HDL-C concentrations in differ- Tables 1 and 2 were excluded from the analyses.
†Adjusted hazard ratios for death from coronary heart disease according to alcohol intake, adjusted for age, educational attainment, body mass index (BMI), smoking, cohabitation status, and physical activity.
‡Total cholesterol, triglycerides, and diastolic blood pressure were added to the model. §High-density lipoprotein cholesterol was added to the model. ent groups thus strongly support the assumption of underreporting (considering that a unit of alcohol contains about 12.5 g) and probably demonstrate more realistic average daily consumption levels for the groups.
The most likely effects of unreliable reporting and loss of heavy drinkers are attenuated hazard ratios and a failure to clearly demonstrate a possible negative effect of excessive drinking. However, such effects hardly raise doubt about the observed protective effect of moderate alcohol consumption or about the conclusion that this protective effect is not primarily mediated by HDL-C.
We have compared the mean levels of HDL-C in our population-based sample with that of population-based samples from Sweden and Denmark, using the results from the MONICA study. In our study, the mean levels are 1.27 mmol/L for men (Table 1 ) and 1.53 mmol/L for women ( Table 2 ). In Northern Sweden, the corresponding values are 1.28 and 1.56, and in Southern Sweden (Gothenburg) the values are 1.22 and 1.56. 20 In Denmark, the mean HDL-C values for men ranged from 1.17 to 1.35 mmol/L, depending on age and year of sampling, whereas they ranged from 1.43 to 1.70 for women. 21 We also looked at the samples from men participating in EUROSTROKE. 22 The mean HDL-C values were 1.05 (Wales), 1.26 (Finland), 1.34 (Netherland), and 1.27 (Russia). Thus, apart from the Welsh values, our mean values are within the range reported in other contemporary European surveys. We also looked at standard deviations, and they are quite similar across European countries. In conclusion, we do not think the Norwegian values are deviant.
Confounding can make observational studies difficult to interpret. 3 Because large-scale and long-term experimental studies on alcohol intake and cardiovascular disease are not possible, one is left with results from observational studies. If confounding is present, one would expect that cohort studies with a relatively high degree of confounder control, such as the present study, should show weaker effects of alcohol. However, that does not seem to be the case, which is in line with what others have found. 1 However, we cannot exclude residual confounding due to other lifestyle or social factors not included in our data set.
Unfortunately, we had no data on 2 other mediators connected to the beneficial effect of alcohol: fibrinogen and hemoglobin A1c, which, together with HDL-C, have been suggested to mediate close to 100% of the effect of alcohol in men and 80% in women. 7 Alcohol consumption can raise HDL-C by increasing the transport rate of apolipoproteins A-I and A-II 23 and by increasing the activity of postheparin plasma lipoprotein lipase. 24 The present results suggest that these alcohol-induced changes may not convey major influences on the risk of coronary heart disease.
But why do 3 prospective studies, such as the Honolulu Heart Program, 10 the Nurses' Health Study, and the Health Professionals Follow-Up Study, 12 as well as a retrospective study in the Boston area, 11 report that HDL-C in large part accounts for the association between alcohol intake and CHD when the present prospective study does not? Our finding is more in agreement with the conclusion in the Finnish cohort. 13 In the Honolulu Heart Study, in which 124 CHD events occurred among 1 768 men, it was reported that the regression coefficient in a survival analysis of time to event according to an increase in 1 mL of alcohol per day, changed from -0.0099 to -0.0052 after the introduction of HDL-C in the regression. 10 However, confidence limits were not provided for these estimates, making it difficult to evaluate whether the coefficients are statistically significantly different. The report from the Nurses' Health Study is a nested case control study with 249 cases and 498 controls. 12 They found that the odds ratio for CHD according to drinking frequency (days per week) is 0.76 (95% CI, 0.59 -0.97) before the introduction of HDL-C in the regression equation, and 0.83 (0.65-1.08) afterward ( Table 2 in reference 12). Thus, the confidence limits are relatively wide and overlapping, and the changes in regression coefficients are not much different from ours. For men (266 cases and 532 controls) in the Health Professionals Follow-Up Study, 12 the corresponding odds ratios are 0.86 (0.74 -1.00) and 0.94 (0.80 -1.00), respectively ( Table 2 in reference 12). There is a possibility that the discrepant findings reported in the literature are within limits that can be accounted for by chance alone. One should, however, keep in mind that our study is based on fatal CHD events, whereas the abovementioned studies to a large extent include nonfatal events.
A new analysis of the Framingham Offspring Study suggests that raising HDL-C by medication is associated with reduced risk of CHD events. 25 However, a recent meta-analysis reports that increasing HDL-C with therapy interfering with lipid metabolism is not associated with a reduction in cardiovascular events. 26 This may imply that also the change in the serum concentration of HDL-C induced by alcohol is more of a biochemical side effect than a direct risk-reducing event. Such a conclusion cannot be safely drawn from this study, but the issue should be further pursued.
The protective effect of moderate alcohol intake on CHD has puzzled researchers for many years. Earlier studies suggested that the increase in HDL-C seen with increasing alcohol intake could be a reasonable explanation for the biological mechanism. However, findings from the present study imply that further research should examine other pathways more closely. This could be of relevance to the design of short-term experimental studies of alcohol intake.
